Core Viewpoint - Lepu Medical's stock price closed at 17.30 yuan, reflecting a decline of 4.95% [1] Group 1: Stock Performance - Lepu Medical's stock reached its highest point of the year at 21.18 yuan on August 25 [2] - The stock has experienced a significant drop since its peak, indicating potential volatility in the market [1] Group 2: Analyst Ratings - China Galaxy Securities maintained a "recommended" rating for Lepu Medical, highlighting the company's dual-driven performance from innovation and consumption [2] - China International Capital Corporation (CICC) analysts expect stable performance and new growth momentum, maintaining an "outperform" rating for the company [2] - Huatai Securities reiterated a "buy" rating, noting accelerated earnings growth in Q2 and a wealth of long-term business highlights [2]
乐普医疗跌4.95% 中国银河等3券商年内高点唱多